Article
MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage
29 Apr 2025
Abstract excerpt
Amplification of the MYC proto-oncogene is frequently observed in various cancer types, including triple-negative breast cancer (TNBC). Emerging evidence suggests that suppression of local antitumor immune responses by MYC, at least in part, explains the tumor-promoting effects of MYC. Specifically, MYC upregulation was demonstrated to suppress the tumor-cell intrinsic activation of a type I interferon response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
